Detail
| LncRNA Name | H19 |
| Synonyms | H19, ASM, ASM1, BWS, D11S813E, LINC00008, NCRNA00008, WT2 |
| Region | GRCh38_11:1995176-2001470 Sequence |
| Ensembl | ENSG00000130600 |
| RefSeq | NR_002196 |
| Circulating | ✘ |
| Drug-resisitant | ✘ |
| Prognostic | ✔ |
| MiRNA | ✘ |
| Variant | ✘ |
| TF | ✘ |
| Methylation | ✘ |
| Cancer Name | malignant melanoma |
| ICD-0-3 | M8720/3 |
| Methods | qPCR, Western blot, Flow cytometry, etc. |
| Sample | melanoma tissues, cell lines (CHL-1, UACC904, A-375, 1205Lu) |
| Expression Pattern | up-regulated |
| Function Description | the high expression of H19 in melanoma tissues was associated with advanced tumor invasion and TNM stage, distal metastasis, lymph node metastasis and shorter overall survival in patients with melanoma. |
| Pubmed ID | 29950863 |
| Year | 2018 |
| Title | lncRNA H19 predicts poor prognosis in patients with melanoma and regulates cell growth, invasion, migration and epithelial-mesenchymal transition in melanoma cells. |
| External Links |
| Links for H19 | GenBank HGNC lncrnadb Noncode |
| Links for malignant melanoma | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.